Case Study Highlights Tardive Dyskinesia and the Importance of Early Diagnosis and Treatment
Researchers of a study assessed tardive dyskinesia (TD). TD is primarily caused by medication use, particularly neuroleptic drugs, and can affect approximately 2% to 5% of patients annually.
Study Reveals Early Warning Signs and Link Between Medication Use and Tardive Dyskinesia, Urges Vigilance for Symptoms
A recent study analyzed the early warning signs and symptoms of tardive dyskinesia (TD), highlighting the importance of recognizing the early indicators of this condition, which is characterized by involuntary movements, particularly in the face and body.
Study Uncovers Neural Network Vulnerability in Tardive Dyskinesia’s Orofacial Symptoms
In a recent study, researchers aimed to understand why tardive dyskinesia (TD) often exhibits orofacial symptoms, while also exploring the neural network involved.
Addressing Prevalence of Tardive Dyskinesia in Long-Term Care Residents: Strategies for Improved Quality of Life and Effective Treatment
This course is designed for long-term care clinicians, including medical directors, physicians, nurse practitioners, physician associates, pharmacists, and psychiatrists, as well as other health professionals caring for older adults.
Understanding and Managing Extrapyramidal Effects Caused by Antipsychotic Medications
Researchers of a study explored the pathophysiology of extrapyramidal effects (EPS) caused by antipsychotic medications, including the delicate balance between therapeutic effects and extrapyramidal effects.
